Next Generation Sequencing Global Market Opportunities And Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market.
Description: Where is the largest and fastest growing market for the next generation sequencing market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global next generation sequencing market opportunities and strategies to 2030 report answers all these questions and many more.
The report covers the following chapters • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report • Report Structure – This section gives the structure of the report and the information covered in the various sections. • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by game type, and by device. • Market Characteristics – The market characteristics section of the report defines and explains the next generation sequencing market. This chapter includes different goods covered in the report and basic definitions. • Trends And Strategies – This chapter describes the major trends shaping the global next generation sequencing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities. • COVID Impact Analysis – This section provides an insight on how the pandemic is impacting the next generation sequencing market. • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2019-2023, 2023-2025 and 2025-2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods. • Regional Analysis – This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region. • Market Segmentation – This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments and sub-segments in the market. • Regional Market Size and Growth – This section contains the region’s market size (2019), historic and forecast (2015-2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa). • Competitive Landscape – This section covers details on the competitive landscape of the global next generation sequencing market, estimated market shares and company profiles of the leading players. • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years. • Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years. • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for next generation sequencing providers in terms of product offerings, geographic expansion, price offerings, marketing strategies and target groups. • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered: The global next generation sequencing market is segmented into - By Product Type: Instruments; Kits and Consumables; Software By Application: Diagnostics; Drug Discovery; Others By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Others
Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies; Pacific Biosciences of California Inc.; QIAGEN
Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia
Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis • Gain a global perspective on the development of the market.
Our reports have been used by over 10K customers, including:
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...
The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public...
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
The POC data management software market was valued at USD 5916.9 million in 2019, and it is expected to reach a value of USD 11,772.2 million by 2025, registering a CAGR of 12.3% over the forecast period from 2020 to 2025. Point-of-care technologies enable hospitals and clinics to invest more time and money in technologies that help accelerate...
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. - According to the Centers for Disease Control and Prevention (CDC) reports,...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Rapid Diagnostics Market Report
The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019–2025.
The global rapid diagnostics market is one of the major segments of the global in-vitro diagnostics...
Traditional aggregometer work on the principle of light transmission. The traditional aggregometer performs light transmission aggregometry (LTA) which was once considered as the gold standard for platelet function testing and is still used for the identification and diagnosis of platelet function defects. Traditional LTA remains the most...
The global autoimmune disease diagnostics market is predicted to reach nearly US$ 18 Billion by 2027. Autoimmune diseases refer to a body’s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There are almost 80 types of autoimmune diseases...
The diagnostic specialty antibodies market is projected to grow with a CAGR of 5.95%, during the forecast period. The advancements in DNA based technologies and diagnostics are expected to boost the market growth. In addition, the high number of patient pool undergoing diagnosis of HIV and growing demand for speciality diagnostics around the...
The exosomes market is expected to register a CAGR of nearly 27.89% during the forecast period. Certain factors that are driving the market growth include increasing prevalence of cancer, technological advancements in exosomes isolation and analytical procedures, and increasing advanced applications of exosomes. The growing prevalence of cancer...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.